Rondo Therapeutics
- Biotech or pharma, therapeutic R&D
Rondo Therapeutics develops innovative bispecific antibody therapies, including tumor-targeted CD28 bispecific antibodies to reinvigorate T cell responses in solid tumors.
Rondo Therapeutics develops innovative bispecific antibody therapies, including tumor-targeted CD28 bispecific antibodies to reinvigorate T cell responses in solid tumors.